This aberrant healing response is likely attributed to a hyperglycemia-induced modulation in cell movement, since supplementation with epidermal growth factor (EGF), a potent stimulator of cell migration, was unable to restore wound closure [32]. The gene discussed is EGF; the disease is Hyperglycemia.